Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CMAX Stock Summary
Top 10 Correlated ETFs
CMAX
In the News
New Strong Sell Stocks for March 28th
ASLE, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2023.
New Strong Sell Stocks for March 20th
CMAX, LNZA and HSON have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2024.
CareMax, Inc. (CMAX) Q3 2023 Earnings Call Transcript
CareMax, Inc. (NASDAQ:CMAX ) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Roger Ou - Senior Vice President of Investor Relations Carlos de Solo - Co-Founder, President, CEO & Director Kevin Wirges - EVP, CFO & Treasurer Conference Call Participants Eduardo Ron - Truist Securities Jessica Tassan - Piper Sandler Jack Slevin - Jefferies Operator Good morning, and welcome to the CareMax, Inc. Third Quarter 2023 Financial Results and Conference Call. [Operator Instructions] I would now like to turn today's call over to Roger Ou, Senior Vice President of Investor Relations.
CareMax Schedules Third Quarter 2023 Earnings Conference Call
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants.
CareMax Strategy Faces High Initial MER Costs
CareMax, Inc. provides value-based care services to seniors in the United States. The firm's strategy is to elect into full-risk MSO Medicare plans even though it may have higher initial expense ratios. With tight liquidity, cash burn and heavy upfront MER costs, I'm Neutral [Hold] on CareMax, Inc. shares for now.
CareMax to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer, Carlos de Solo, and Chief Financial Officer, Kevin Wirges, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023, at 7:30 am Eastern Time. A live webcast and replay of the event will be available on CareMax's investor relations webs.
CareMax, Inc. (CMAX) Reports Q2 Loss, Tops Revenue Estimates
CareMax, Inc. (CMAX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.11 per share a year ago.
CareMax Schedules Second Quarter 2023 Earnings Conference Call
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that it will release its financial results for the second quarter 2023 before the opening of the financial markets on Wednesday, August 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for.
CareMax: Reiterate Buy On Potential Future Growth
CareMax offers a unique healthcare delivery model for managing chronic diseases and value-based care for the elderly population, with potential for significant growth in the expanding Medicare market. CMAX's integrated approach, including its Clinic strategy and wellness center, sets it apart from competitors and improves patient outcomes while reducing healthcare costs. Despite execution risks in venturing into new markets, CMAX's established presence in South Florida and the integration with Steward Health Care System offer a strong foundation for future growth and improved financial performance.
CareMax to Present at the Jefferies Healthcare Conference
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer, Carlos de Solo, and Chief Financial Officer, Kevin Wirges, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023, at 11:00 am Eastern Time. A live webcast and replay of the event will be available on CareMax's investor relations website at ir.caremax.com. About.
CMAX Financial details
CMAX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 1.29 | 5.76 | 7.01 | 201.49 | |
Net income per share | 0 | 0.07 | -0.13 | -0.42 | -183.31 | |
Operating cash flow per share | 0 | 0.07 | -0.46 | -0.76 | -12.58 | |
Free cash flow per share | 0 | 0.04 | -0.6 | -0.84 | -16.5 | |
Cash per share | 0 | 0.06 | 0.93 | 0.46 | 17.58 | |
Book value per share | 0 | 0.08 | 9.84 | 6.88 | 16.48 | |
Tangible book value per share | 0 | -0.15 | -0.37 | -2.27 | -52.75 | |
Share holders equity per share | 0 | 0.08 | 9.84 | 6.88 | 16.48 | |
Interest debt per share | 0 | 0.36 | 2.37 | 4.26 | 120.51 | |
Market cap | 0 | 37.56B | 11.83B | 9.85B | 55.73M | |
Enterprise value | -4.44M | 37.58B | 11.9B | 10.18B | 482.14M | |
P/E ratio | 0 | 6.32K | -1.77K | -260.71 | -0.08 | |
Price to sales ratio | 0 | 363.14 | 40 | 15.61 | 0.07 | |
POCF ratio | 0 | 7.06K | -495.9 | -144.45 | -1.19 | |
PFCF ratio | 0 | 11.87K | -385 | -130.23 | -0.91 | |
P/B Ratio | 0 | 5.58K | 23.41 | 15.91 | 0.91 | |
PTB ratio | 0 | 5.58K | 23.41 | 15.91 | 0.91 | |
EV to sales | -0.05 | 363.35 | 40.23 | 16.12 | 0.64 | |
Enterprise value over EBITDA | -0.59 | 3.36K | -340.96 | -1.51K | -7.56 | |
EV to operating cash flow | -0.63 | 7.07K | -498.81 | -149.17 | -10.28 | |
EV to free cash flow | -0.71 | 11.87K | -387.25 | -134.48 | -7.84 | |
Earnings yield | 0 | 0 | 0 | 0 | -12.26 | |
Free cash flow yield | 0 | 0 | 0 | -0.01 | -1.1 | |
Debt to equity | 3.11 | 4.06 | 0.23 | 0.59 | 6.43 | |
Debt to assets | 0.66 | 0.71 | 0.18 | 0.31 | 0.63 | |
Net debt to EBITDA | -0.59 | 2 | -1.99 | -47.75 | -6.69 | |
Current ratio | 3.02 | 2.73 | 4.92 | 2.55 | 0.42 | |
Interest coverage | 0 | 5.84 | -6.08 | -1.43 | -1.89 | |
Income quality | 1.17 | 0.7 | 3.57 | 1.8 | 0.07 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.72 | 0.62 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.13 | 0.07 | 0.14 | 0.12 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.44 | 0.48 | 0.8 | 0.7 | 0.41 | |
Capex to operating cash flow | -0.1 | -0.4 | 0.29 | 0.11 | 0.31 | |
Capex to revenue | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 | |
Capex to depreciation | -0.75 | -1.43 | -0.52 | -0.34 | -0.37 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.02 | 0.01 | |
Graham number | 0 | 0.37 | 5.37 | 8.07 | 260.74 | |
ROIC | 0.32 | 0.22 | -0.04 | -0.02 | -0.19 | |
Return on tangible assets | 0.44 | 0.3 | -0.05 | -0.11 | -1.87 | |
Graham Net | 0 | -0.24 | -1.32 | -4.4 | -110.06 | |
Working capital | 6.72M | 9.43M | 86.09M | 120.01M | -255.46M | |
Tangible asset value | -5.67M | -11.92M | -19.01M | -204.68M | -196.64M | |
Net current asset value | -9.32M | -16.9M | -39.68M | -353.86M | -378.51M | |
Invested capital | 3.11 | 4.06 | 0.23 | 0.59 | 6.43 | |
Average receivables | 0 | 7.43M | 25.83M | 96.52M | 132.9M | |
Average payables | 0 | 1.28M | 2.08M | 5.4M | 6.98M | |
Average inventory | 0 | 12.81K | 282.5K | 636.5K | 361.5K | |
Days sales outstanding | 20.9 | 34.12 | 51.83 | 87.35 | 55.77 | |
Days payables outstanding | 10.71 | 4.57 | 4.29 | 5.09 | 11.89 | |
Days of inventory on hand | 0.08 | 0.07 | 0.76 | 0.48 | 0 | |
Receivables turnover | 17.47 | 10.7 | 7.04 | 4.18 | 6.55 | |
Payables turnover | 34.07 | 79.91 | 84.99 | 71.66 | 30.7 | |
Inventory turnover | 4.86K | 5.56K | 480.57 | 761.87 | 192.66M | |
ROE | 1.17 | 0.88 | -0.01 | -0.06 | -11.12 | |
Capex per share | 0 | -0.03 | -0.13 | -0.08 | -3.92 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.63 | 1.56 | 2.01 | 1.8 | 40.59 | |
Net income per share | 0.1 | -0.74 | -0.29 | -0.92 | -124.53 | |
Operating cash flow per share | -0.28 | -0.2 | -0.19 | -0.17 | 4.15 | |
Free cash flow per share | -0.31 | -0.22 | -0.22 | -0.2 | 2.39 | |
Cash per share | 0.41 | 0.4 | 0.49 | 0.29 | 17.52 | |
Book value per share | 6.14 | 4.87 | 5.59 | 4.68 | 16.43 | |
Tangible book value per share | -2.03 | -1.63 | -0.81 | -0.94 | -52.57 | |
Share holders equity per share | 6.14 | 4.87 | 5.59 | 4.68 | 16.43 | |
Interest debt per share | 3.69 | 3.72 | 4.19 | 4.01 | 109.97 | |
Market cap | 11.05B | 8.88B | 10.42B | 7.13B | 55.92M | |
Enterprise value | 11.37B | 9.24B | 10.82B | 7.56B | 482.32M | |
P/E ratio | 264.69 | -27.06 | -80.43 | -17.28 | -0.03 | |
Price to sales ratio | 67.25 | 51.36 | 46.41 | 35.32 | 0.37 | |
POCF ratio | -388.91 | -408.57 | -484.09 | -371.61 | 3.6 | |
PFCF ratio | -356.44 | -369.71 | -425.76 | -324.68 | 6.26 | |
P/B Ratio | 17.83 | 16.46 | 16.68 | 13.59 | 0.91 | |
PTB ratio | 17.83 | 16.46 | 16.68 | 13.59 | 0.91 | |
EV to sales | 69.21 | 53.43 | 48.19 | 37.46 | 3.18 | |
Enterprise value over EBITDA | 7.45K | -2.26K | 1.14K | -68.44 | -6.73 | |
EV to operating cash flow | -400.24 | -425.06 | -502.7 | -394.1 | 31.06 | |
EV to free cash flow | -366.82 | -384.62 | -442.13 | -344.33 | 54.03 | |
Earnings yield | 0 | -0.01 | 0 | -0.01 | -8.33 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0.16 | |
Debt to equity | 0.59 | 0.75 | 0.73 | 0.88 | 6.43 | |
Debt to assets | 0.31 | 0.37 | 0.4 | 0.44 | 0.63 | |
Net debt to EBITDA | 210.8 | -87.57 | 42.12 | -3.91 | -5.95 | |
Current ratio | 2.55 | 2.61 | 2.23 | 1.8 | 0.42 | |
Interest coverage | -0.66 | -1.01 | -0.28 | 8.38 | -4.96 | |
Income quality | -2.72 | 0.26 | 0.66 | 0.19 | -0.03 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.14 | 0.09 | 0.1 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.7 | 0.66 | 0.62 | 0.59 | 0.41 | |
Capex to operating cash flow | 0.09 | 0.11 | 0.14 | 0.14 | -0.43 | |
Capex to revenue | -0.02 | -0.01 | -0.01 | -0.01 | -0.04 | |
Capex to depreciation | -0.36 | -0.35 | -0.23 | -0.28 | -0.65 | |
Stock based compensation to revenue | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
Graham number | 3.78 | 9 | 6.04 | 9.84 | 214.54 | |
ROIC | 0.01 | -0.01 | 0 | -0.11 | -0.15 | |
Return on tangible assets | 0.03 | -0.22 | -0.07 | -0.24 | -1.28 | |
Graham Net | -3.92 | -3.56 | -3.15 | -3.53 | -109.69 | |
Working capital | 120.01M | 129.57M | 120.58M | 78.32M | -255.46M | |
Tangible asset value | -204.68M | -181.07M | -90.68M | -104.92M | -196.64M | |
Net current asset value | -353.86M | -347.94M | -307.82M | -356.84M | -378.51M | |
Invested capital | 0.59 | 0.75 | 0.73 | 0.88 | 6.43 | |
Average receivables | 118.4M | 155.01M | 159.4M | 150.2M | 127.67M | |
Average payables | 10.55M | 7.91M | 8.41M | 9.01M | 7.81M | |
Average inventory | 817K | 361.5K | 0.5 | 0.5 | 1 | |
Days sales outstanding | 82.75 | 82.72 | 64.08 | 62.68 | 68.02 | |
Days payables outstanding | 4.84 | 4.9 | 3.96 | 4.6 | 11.35 | |
Days of inventory on hand | 0.46 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.09 | 1.09 | 1.4 | 1.44 | 1.32 | |
Payables turnover | 18.58 | 18.36 | 22.73 | 19.58 | 7.93 | |
Inventory turnover | 197.51 | 149.3M | 0 | 182.97M | 49.78M | |
ROE | 0.02 | -0.15 | -0.05 | -0.2 | -7.58 | |
Capex per share | -0.03 | -0.02 | -0.03 | -0.02 | -1.77 |
CMAX Frequently Asked Questions
What is CareMax, Inc. stock symbol ?
CareMax, Inc. is a US stock , located in Miami of Fl and trading under the symbol CMAX
Is CareMax, Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $6. The lowest prediction is $6 and the highest is $6
What is CMAX stock prediction ?
What is CareMax, Inc. stock quote today ?
CareMax, Inc. stock price is $4.82 today.
Is CareMax, Inc. stock public?
Yes, CareMax, Inc. is a publicly traded company.